Dendritic cells and aging: consequences for autoimmunity

References

• Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann. Allergy Asthma Immunol.104(3), 183–190 (2010).
   PubMed Web of Science ®Google Scholar
• Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun. Rev.3(5), 401–406 (2004).
   PubMed Web of Science ®Google Scholar
• Pawelec G, Larbi A. Immunity and ageing in man: annual review 2006/2007. Exp. Gerontol.43(1), 34–38 (2008).
   PubMed Web of Science ®Google Scholar
• Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM. Aging of the innate immune system. Curr. Opin. Immunol.22(4), 507–513 (2010).
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine18(16), 1717–1720 (2000).
   PubMed Web of Science ®Google Scholar
• Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J. Pathol.211(2), 144–156 (2007).
   PubMed Web of Science ®Google Scholar
• Agrawal S, Agrawal A, Doughty B et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol.171(10), 4984–4989 (2003).
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science327(5963), 291–295 (2010).
   PubMed Web of Science ®Google Scholar
• Manicassamy S, Pulendran B. Modulation of adaptive immunity with Toll-like receptors. Semin. Immunol.21(4), 185–193 (2009).
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Ann. Rev. Immunol.21, 685–711 (2003).
   PubMed Web of Science ®Google Scholar
• Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med.196(8), 1091–1097 (2002).
   PubMed Web of Science ®Google Scholar
• Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl Acad. Sci. USA99(1), 351–358 (2002).
   PubMed Web of Science ®Google Scholar
• Bratton DL, Henson PM. Autoimmunity and apoptosis: refusing to go quietly. Nat. Med.11(1), 26–27 (2005).
   PubMed Web of Science ®Google Scholar
• Wu X, Molinaro C, Johnson N, Casiano CA. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity. Arthritis Rheum.44(11), 2642–2652 (2001).
   PubMed Web of Science ®Google Scholar
• Joaquin AM, Gollapudi S. Functional decline in aging and disease: a role for apoptosis. J. Am. Geriatr. Soc.49(9), 1234–1240 (2001).
   PubMed Web of Science ®Google Scholar
• Zhang JH, Zhang Y, Herman B. Caspases, apoptosis and aging. Ageing Res. Rev.2(4), 357–366 (2003).
   PubMed Web of Science ®Google Scholar
• Behrens MI, Silva M, Schmied A et al. Age-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress. J. Gerontol. A. Biol. Sci. Med. Sci.66(7), 732–740 (2011).
   PubMedGoogle Scholar
• Gupta S, Young T, Yel L, Su H, Gollapudi S. Differential sensitivity of naive and subsets of memory CD4+ and CD8+ T cells to hydrogen peroxide-induced apoptosis. Genes Immun.8(7), 560–569 (2007).
   PubMedGoogle Scholar
• Gaipl US, Brunner J, Beyer TD, Voll RE, Kalden JR, Herrmann M. Disposal of dying cells: a balancing act between infection and autoimmunity. Arthritis Rheum.48(1), 6–11 (2003).
   PubMed Web of Science ®Google Scholar
• Ip WK, Lau YL. Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J. Immunol.173(1), 189–196 (2004).
   PubMed Web of Science ®Google Scholar
• Agrawal A, Tay J, Ton S, Agrawal S, Gupta S. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J. Immunol.182(2), 1138–1145 (2009).
   PubMedGoogle Scholar
• Agrawal A, Tay J, Yang GE, Agrawal S, Gupta S. Age-associated epigenetic modifications in human DNA increase its immunogenicity. Aging2(2), 93–100 (2010).
   PubMedGoogle Scholar
• Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity. Cell Immunol.233(2), 102–108 (2005).
   PubMed Web of Science ®Google Scholar
• Carette S, Marcoux S, Gingras S. Postmenopausal hormones and the incidence of rheumatoid arthritis. J. Rheumatol.16(7), 911–913 (1989).
   PubMedGoogle Scholar
• Hasler P, Zouali M. B cell receptor signaling and autoimmunity. FASEB J.15(12), 2085–2098 (2001).
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Garcia-Carrasco M, Brito MP, Lopez-Soto A, Font J. Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus12(5), 341–355 (2003).
   PubMed Web of Science ®Google Scholar
• Somers EC, Thomas SL, Smeeth L, Schoonen WM, Hall AJ. Incidence of systemic lupus erythematosus in the United Kingdom, 1990–1999. Arthritis Rheum.57(4), 612–618 (2007).
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Utsuyama M, Kurashima C, Hirokawa K. Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice. Clin. Exp. Immunol.78(1), 120–126 (1989).
   PubMedGoogle Scholar
• Yoshioka H, Yoshida H, Doi T et al. Autoimmune abnormalities in a murine model of accelerated senescence. Clin. Exp. Immunol.75(1), 129–135 (1989).
   PubMed Web of Science ®Google Scholar
• Bhatnagar H, Kala S, Sharma L, Jain S, Kim KS, Pal R. Serum and organ-associated anti-hemoglobin humoral autoreactivity: association with anti-Sm responses and inflammation. Eur. J. Immunol.41(2), 537–548 (2011).
   PubMedGoogle Scholar
• Srivastava R, Yu S, Parks BW, Black LL, Kabarowski JH. Autoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice. Arthritis Rheum.63(1), 201–211 (2011).
   PubMedGoogle Scholar
• Mariotti S, Sansoni P, Barbesino G et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet339(8808), 1506–1508 (1992).
   PubMed Web of Science ®Google Scholar
• Sireci G, Russo D, Dieli F et al. Immunoregulatory role of Jα281 T cells in aged mice developing lupus-like nephritis. Eur. J. Immunol.37(2), 425–433 (2007).
   PubMedGoogle Scholar
• Aprahamian T, Takemura Y, Goukassian D, Walsh K. Ageing is associated with diminished apoptotic cell clearance in vivo. Clin. Exp. Immunol.152(3), 448–455 (2008).
   PubMed Web of Science ®Google Scholar
• Stacy S, Krolick KA, Infante AJ, Kraig E. Immunological memory and late onset autoimmunity. Mech. Ageing Dev.123(8), 975–985 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson SA, Cambier JC. Ageing, autoimmunity and arthritis: senescence of the B cell compartment – implications for humoral immunity. Arthritis Res. Ther.6(4), 131–139 (2004).
   PubMed Web of Science ®Google Scholar
• Kline GH, Hayden TA, Klinman NR. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J. Immunol.162(6), 3342–3349 (1999).
   PubMed Web of Science ®Google Scholar
• Larbi A, Fulop T, Pawelec G. Immune receptor signaling, aging and autoimmunity. Adv. Exp. Med. Biol.640, 312–324 (2008).
   PubMed Web of Science ®Google Scholar
• Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol. Today21(10), 515–521 (2000).
   PubMedGoogle Scholar
• Desai A, Grolleau-Julius A, Yung R. Leukocyte function in the aging immune system. J. Leukoc. Biol.87(6), 1001–1009 (2010).
   PubMed Web of Science ®Google Scholar
• Sansoni P, Vescovini R, Fagnoni F et al. The immune system in extreme longevity. Exp. Gerontol.43(2), 61–65 (2008).
   PubMed Web of Science ®Google Scholar
• Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol.30(7), 306–312 (2009).
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Weyand CM. Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity – catalysts of autoimmunity and chronic inflammation. Arthritis Res. Ther.5(5), 225–234 (2003).
   PubMed Web of Science ®Google Scholar
• Effros RB. Replicative senescence of CD8 T cells: effect on human ageing. Exp. Gerontol.39(4), 517–524 (2004).
   PubMed Web of Science ®Google Scholar
• Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol. Rev.205, 147–157 (2005).
   PubMed Web of Science ®Google Scholar
• Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum.31(6), 784–788 (1988).
   PubMed Web of Science ®Google Scholar
• Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J. Gerontol. A. Biol. Sci. Med. Sci.61(6), 575–584 (2006).
   PubMed Web of Science ®Google Scholar
• Haynes L, Maue AC. Effects of aging on T cell function. Curr. Opin. Immunol.21(4), 414–417 (2009).
   PubMed Web of Science ®Google Scholar
• Lee JS, Lee WW, Kim SH et al. Age-associated alteration in naive and memory Th17 cell response in humans. Clin. Immunol.140(1), 84–91 (2011).
   PubMedGoogle Scholar
• Hwang KA, Kim HR, Kang I. Aging and human CD4(+) regulatory T cells. Mech. Ageing Dev.130(8), 509–517 (2009).
   PubMedGoogle Scholar
• Gregg R, Smith CM, Clark FJ et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin. Exp. Immunol.140(3), 540–546 (2005).
   PubMed Web of Science ®Google Scholar
• Chiu BC, Stolberg VR, Zhang H, Chensue SW. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice. Mech. Ageing Dev.128(11–12), 618–627 (2007).
   PubMed Web of Science ®Google Scholar
• Rosenkranz D, Weyer S, Tolosa E et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J. Neuroimmunol.188(1–2), 117–127 (2007).
   PubMed Web of Science ®Google Scholar
• Cvetanovich GL, Hafler DA. Human regulatory T cells in autoimmune diseases. Curr. Opin. Immunol.22(6), 753–760 (2010).
   PubMed Web of Science ®Google Scholar
• Vila J, Isaacs JD, Anderson AE. Regulatory T cells and autoimmunity. Curr. Opin. Hematol.16(4), 274–279 (2009).
   PubMed Web of Science ®Google Scholar
• Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol.8(4), 345–350 (2007).
   PubMed Web of Science ®Google Scholar
• Johnson TE. Recent results: biomarkers of aging. Exp. Gerontol.41(12), 1243–1246 (2006).
   PubMed Web of Science ®Google Scholar
• Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp. Gerontol.39(5), 687–699 (2004).
   PubMed Web of Science ®Google Scholar
• Deon D, Ahmed S, Tai K et al. Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts. J. Immunol.167(9), 5395–5403 (2001).
   PubMedGoogle Scholar
• Jensen SS, Gad M. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J. Inflamm. (Lond.)7, 37 (2010).
   PubMedGoogle Scholar
• Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med.191(3), 411–416 (2000).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature392(6673), 245–252 (1998).
   PubMed Web of Science ®Google Scholar
• Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med.194(6), 769–779 (2001).
   PubMed Web of Science ®Google Scholar
• Hardin JA. Dendritic cells: potential triggers of autoimmunity and targets for therapy. Ann. Rheum. Dis.64(4), 86–90 (2005).
   Google Scholar
• Ludewig B, Junt T, Hengartner H, Zinkernagel RM. Dendritic cells in autoimmune diseases. Curr. Opin. Immunol.13(6), 657–662 (2001).
   PubMed Web of Science ®Google Scholar
• Mehling A, Beissert S. Dendritic cells under investigation in autoimmune disease. Crit. Rev. Biochem. Mol. Biol.38(1), 1–21 (2003).
   PubMed Web of Science ®Google Scholar
• Hemmi H, Yoshino M, Yamazaki H et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells. Int. Immunol.13(5), 695–704 (2001).
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Hori Y, Sato S, Fitzpatrick TB, Martuza RL. The nature and origin of the melanin macroglobule. J. Invest. Dermatol.83(2), 134–139 (1984).
   PubMedGoogle Scholar
• Steinman RM. Dendritic cells: understanding immunogenicity. Eur. J. Immunol.37(Suppl. 1), S53–S60 (2007).
   PubMed Web of Science ®Google Scholar
• Bluestone JA. Mechanisms of tolerance. Immunol. Rev.241(1), 5–19 (2011).
   PubMed Web of Science ®Google Scholar
• Ohashi PS, DeFranco AL. Making and breaking tolerance. Curr. Opin. Immunol.14(6), 744–759 (2002).
   PubMed Web of Science ®Google Scholar
• Bayry J, Thirion M, Delignat S et al. Dendritic cells and autoimmunity. Autoimmun. Rev.3(3), 183–187 (2004).
   PubMed Web of Science ®Google Scholar
• Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol.172(8), 4676–4680 (2004).
   PubMed Web of Science ®Google Scholar
• Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol.6(3), 280–286 (2005).
   PubMed Web of Science ®Google Scholar
• Belz GT, Behrens GM, Smith CM et al. The CD8α(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med.196(8), 1099–1104 (2002).
   PubMed Web of Science ®Google Scholar
• Morelli AE, Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev.196, 125–146 (2003).
   PubMed Web of Science ®Google Scholar
• Li HS, Verginis P, Carayanniotis G. Maturation of dendritic cells by necrotic thyrocytes facilitates induction of experimental autoimmune thyroiditis. Clin. Exp. Immunol.144(3), 467–474 (2006).
   PubMedGoogle Scholar
• Asea A. Heat shock proteins and toll-like receptors. Handb. Exp. Pharmacol.(183), 111–127 (2008).
   Google Scholar
• Calderwood SK, Mambula SS, Gray PJ Jr. Extracellular heat shock proteins in cell signaling and immunity. Ann. NY Acad. Sci.1113, 28–39 (2007).
   PubMed Web of Science ®Google Scholar
• Robek MD, Boyd BS, Chisari FV. Lambda interferon inhibits hepatitis B and C virus replication. J. Virol.79(6), 3851–3854 (2005).
   PubMed Web of Science ®Google Scholar
• Biron CA. Interferons α and β as immune regulators – a new look. Immunity14(6), 661–664 (2001).
   PubMed Web of Science ®Google Scholar
• Hoeffel G, Ripoche AC, Matheoud D et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity27(3), 481–492 (2007).
   PubMed Web of Science ®Google Scholar
• Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science294(5546), 1540–1543 (2001).
   PubMed Web of Science ®Google Scholar
• Blomberg S, Eloranta ML, Cederblad B, Nordlin K, Alm GV, Ronnblom L. Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus. Lupus10(7), 484–490 (2001).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol.5(4), 296–306 (2005).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Pascual V. Type 1 interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity25(3), 383–392 (2006).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Pascual V, Palucka AK. Autoimmunity through cytokine-induced dendritic cell activation. Immunity20(5), 539–550 (2004).
   PubMed Web of Science ®Google Scholar
• Hammad H, Smits HH, Ratajczak C et al. Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22. Eur. Cytokine Netw.14(4), 219–228 (2003).
   PubMed Web of Science ®Google Scholar
• Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. North Am.23(1), 15–39 (2003).
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Kuhn U, Muller G et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol.27(12), 3135–3142 (1997).
   PubMed Web of Science ®Google Scholar
• Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol.178(11), 6912–6922 (2007).
   PubMed Web of Science ®Google Scholar
• Panda A, Qian F, Mohanty S et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol.184(5), 2518–2527 (2010).
   PubMed Web of Science ®Google Scholar
• Hardin JA. Directing autoimmunity to nucleoprotein particles: the impact of dendritic cells and interferon α in lupus. J. Exp. Med.197(6), 681–685 (2003).
   PubMed Web of Science ®Google Scholar
• Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum.41(7), 1241–1250 (1998).
   PubMed Web of Science ®Google Scholar
• Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ.6(1), 6–12 (1999).
   PubMed Web of Science ®Google Scholar
• Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol.2(12), 965–975 (2002).
   PubMed Web of Science ®Google Scholar
• Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med.188(2), 387–392 (1998).
   PubMed Web of Science ®Google Scholar
• Shoshan Y, Mevorach D. Accelerated autoimmune disease in MRL/MpJ-Fas(lpr) but not in MRL/MpJ following immunization with high load of syngeneic late apoptotic cells. Autoimmunity37(2), 103–109 (2004).
   PubMed Web of Science ®Google Scholar
• Clayton AR, Prue RL, Harper L, Drayson MT, Savage CO. Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum.48(8), 2362–2374 (2003).
   PubMedGoogle Scholar
• Kouzarides T. Chromatin modifications and their function. Cell128(4), 693–705 (2007).
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. The language of covalent histone modifications. Nature403(6765), 41–45 (2000).
   PubMed Web of Science ®Google Scholar
• Kouzarides T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev.12(2), 198–209 (2002).
   PubMed Web of Science ®Google Scholar
• Berger SL. An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene20(24), 3007–3013 (2001).
   PubMed Web of Science ®Google Scholar
• Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol.6(11), 838–849 (2005).
   PubMed Web of Science ®Google Scholar
• Peters AH, Mermoud JE, O’Carroll D et al. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat. Genet.30(1), 77–80 (2002).
   PubMed Web of Science ®Google Scholar